Comparison of Two Commercial Molecular Tests and a Laboratory-Developed Modification of the CDC 2019-nCoV Reverse Transcriptase PCR Assay for the Detection of SARS-CoV-2

We compared the ability of 2 commercial molecular amplification assays (RealTime SARS-CoV-2 on the m2000 [abbreviated ACOV; Abbott] and ID Now COVID-19 [abbreviated IDNOW; Abbott]) and a laboratory-developed test (modified CDC 2019-nCoV reverse transcriptase PCR [RT-PCR] assay with RNA extraction by...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Nicholas M., Li, Haiying, Schejbal, Debra, Lindsley, Jennifer, Hayden, Mary K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Virology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383545/
https://www.ncbi.nlm.nih.gov/pubmed/32461287
http://dx.doi.org/10.1128/JCM.00938-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383545/
https://www.ncbi.nlm.nih.gov/pubmed/32461287
http://dx.doi.org/10.1128/JCM.00938-20

Ejemplares similares